FIELD: medicine; pharmacology; chemical-pharmaceutical industry.
SUBSTANCE: invention relates to novel compositions for the treatment and prevention of influenza and acute respiratory viral diseases, containing 2-(imidazol-4-yl)-ethanamide of pentanedioic acid and N,N'-bis-[2-(1H-imidazol-4-yl)ethyl]pentanediamide and/or pharmaceutically acceptable salts thereof, compositions based on said compositions, a medicinal agent based on said compositions or said pharmaceutical composition and a finished dosage form based on said compositions, said pharmaceutical composition or said medicinal agent. Invention also relates to use of said compositions, a pharmaceutical composition, a drug or a finished dosage form for treating and preventing influenza and acute respiratory viral diseases.
EFFECT: there are presented new formulations of 2-(imidazol-4-yl)-ethanamide of pentanedioic acid for treatment and prevention of viral diseases.
14 cl, 4 tbl, 5 ex
